Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Danaher Corp (NY: DHR )

272.09 -2.29 (-0.83%)
Official Closing Price Updated: 7:00 PM EDT, Oct 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,359,614
Open 273.10
Bid (Size) 269.45 (1)
Ask (Size) 278.00 (2)
Prev. Close 274.38
Today's Range 270.29 - 274.21
52wk Range 182.09 - 281.70
Shares Outstanding 724,000,000
Dividend Yield 0.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Earnings Preview: Danaher
Via Benzinga
Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential'
Hedge fund manager Daniel Loeb is optimistic about the economy and market and he sees Trump likely retaking White House. 
Via Benzinga
Topics Economy Government
Exposures Economy Political

Performance

YTD
+15.89%
+15.89%
1 Month
-0.39%
-0.39%
3 Month
+8.45%
+8.45%
6 Month
+15.25%
+15.25%
1 Year
+33.34%
+33.34%

More News

Read More
This Is What Whales Are Betting On Danaher
Via Benzinga
Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR).
Via Chartmill
Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years
Via Benzinga
Looking Into Danaher's Recent Short Interest
Via Benzinga
DANAHER CORP (NYSE:DHR) can be considered a quality stock. Here's why.
Via Chartmill
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Spotlight on Danaher: Analyzing the Surge in Options Activity
Via Benzinga
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
Via Benzinga
Danaher Unusual Options Activity
Via Benzinga
Momentum Investing Gives You An Edge, Until It Doesn’t
Via Talk Markets
Unpacking the Latest Options Trading Trends in Danaher
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
Smart Money Is Betting Big In DHR Options
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,200 Today
Via Benzinga
Behind the Scenes of Danaher's Latest Options Trends
Via Benzinga
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Via MarketBeat
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
Via Talk Markets
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
$1000 Invested In Danaher 10 Years Ago Would Be Worth This Much Today
Via Benzinga
(DHR) - Analyzing Danaher's Short Interest
Via Benzinga
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
Via Benzinga
Biogen, Beckman Coulter and Fujirebio to Collaborate on Blood-Based Biomarkers and Test for Tau Pathology in Alzheimer’s Disease
From Biogen Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.